On May 27, Shares of Celgene Corporation (NASDAQ:CELG) saw unusually large options trading activity on Tuesday. Stock traders bought 6,046 put options on the company, Stock Ratings Network.com reports. This represents an increase of 103% compared to the average daily volume of 2,979 put options. Celgene Corporation (NASDAQ:CELG) net profit margin is 19.90% and weekly performance is 4.50%. On last trading day company shares ended up $154.30. Analysts mean target price for the company is $191.67. Celgene Corporation (NASDAQ:CELG) distance from 50-day simple moving average (SMA50) is 6.17%.
On May 21, Ballard Power Systems (NASDAQ:BLDP) congratulates transit authority Regional Verkehr Koln (RVK) of Cologne, Germany as well as Van Hool NV, Europe’s fourth largest bus manufacturer, for delivery of two (2) 13 meter (40 foot) buses powered by Ballard’s FCvelocity®-HD6 fuel cell modules. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) shares advanced 19.02% in last trading session and ended the day on $3.88. Gross Margin is 27.50 % and its return on assets is -12.60%. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) quarterly performance is 15.82%.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) is pleased to announce Professor Ira Shoulson will join the Company’s Board of Directors as a Non-Executive Director. Professor Shoulson is one of the world’s foremost experts in neurodegenerative diseases and movement disorders, and the founder of international academic consortia the Huntington Study Group and Parkinson Study Group, which have been instrumental in the development of innovative drugs to treat these disabling neurological conditions. This is his first company Board position. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares moved up 10.53% in last trading session and was closed at $2.10, while trading in range of $1.95 – $2.24. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) year to date (YTD) performance is -70.04%.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) on May 8 announced corporate and financial results for the first quarter ended March 31, 2014. For the three months ended March 31, 2014, Orexigen reported a net loss of $24.9 million, or $0.23 per share, as compared to a net loss of $19.4 million, or $0.21 per share, for the first quarter of 2013. Total operating expenses for the first quarter of 2014 were $24.0 million compared to $20.3 million for the first quarter of 2013.Orexigen Therapeutics, Inc. (NASDAQ:OREX) ended the last trading day at $6.26. Company weekly volatility is calculated as 5.89% and price to cash ratio as 4.69. Orexigen Therapeutics, Inc. (NASDAQ:OREX) showed a positive weekly performance of 15.93%.
O May 21, Bayer AG (ADR) (NASDAQ:BAYRY) announced its earnings results on Tuesday. The company reported $2.35 earnings per share for the quarter, missing the analysts’ consensus estimate of $2.47 by $0.12,StockRatingsNetwork.com reports. Bayer AG (ADR) (OTCMKTS:BAYRY) On last trading day company shares ended up $142.14 .
Leave a Reply